Abstract 12763: Imatinib Mesylate Attenuates Hypertensive Cardiovascular Remodeling in Spontaneously Hypertensive Rats

Sang‐Hyun Ihm(The Catholic University of Korea Bucheon St. Mary's Hospital), Jae‐Hyung Kim(Catholic University of Korea), Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital), Kiyuk Chang(St. Mary's Hospital), Ki‐Bae Seung, Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Hee Jung Lee(Korea Institute of Materials Science), Hyo Eun Park, Chanseok Park(Catholic University of Korea), Wook-Sung Chung, Okran Kim(Catholic University of Korea), Myung Hee Kim
Circulation
November 22, 2011
Cited by 0

Related Papers

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304